Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Previously Approved Collection; Application for Registration and Application for Registration Renewal; DEA Forms 224, 224A, 81109-81110 [2024-23027]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 194 / Monday, October 7, 2024 / Notices
U.S.C. appendix 3; or (ii) by U.S.
Government employees and contract
personnel,2 solely for cybersecurity
purposes. All nonconfidential written
submissions will be available for public
inspection at the Office of the Secretary
and on EDIS.3
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of §§ 201.10 and 210.8(c) of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.8(c)).
By order of the Commission.
Issued: October 1, 2024.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2024–23039 Filed 10–4–24; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
[OMB Number 1117–0014]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Revision of a
Previously Approved Collection;
Application for Registration and
Application for Registration Renewal;
DEA Forms 224, 224A
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day notice.
AGENCY:
The Drug Enforcement
Administration (DEA), Department of
Justice (DOJ), will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
December 6, 2024.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Heather E. Achbach, Regulatory Drafting
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
2 All contract personnel will sign appropriate
nondisclosure agreements.
3 Electronic Document Information System
(EDIS): https://edis.usitc.gov.
VerDate Sep<11>2014
17:11 Oct 04, 2024
Jkt 262001
and Policy Support Section, Drug
Enforcement Administration; Mailing
Address: 8701 Morrissette Drive,
Springfield, Virginia 22152; Telephone:
(571) 776–3882; Email: DEA.PRA@
dea.gov or Heather.E.Achbach@dea.gov.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Bureau of Justice
Statistics, including whether the
information will have practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Abstract: The Controlled Substances
Act (CSA) (21 U.S.C. 801–971) requires
all persons that manufacture, distribute,
dispense, conduct research with,
import, or export any controlled
substance to obtain a registration issued
by the Attorney General. DEA would be
revising the proposed information
collection instruments as statutorily
mandated by the Protecting Patient
Access to Emergency Medications Act of
2017. DEA would be creating a new
business activity and adding it to forms
DEA–224 and DEA–224A to allow
Emergency Medical Services agencies to
register as such, if authorized by state
law. This new business activity would
allow EMS agencies to obtain a DEA
registration that will permit EMS
agencies to deliver controlled
substances to their designated locations
without obtaining a separate registration
as a Distributor. This registration would
allow EMS personnel to administer
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
81109
controlled substances outside the
physical presence of a medical director
or authorizing medical professional in
the course of providing emergency
medical services. Upon issuance of an
EMS agency registration, the EMS
agency should use the online system to
identify all of the locations it intends to
designate under the EMS agencies’ DEA
registration. This proposed collection
would also allow EMS agencies to
choose the option of a single registration
in each state where the EMS agency
operates. If the agency operates EMS
facilities in multiple states, the agency
must have a separate registration in each
state where the agency operates.
Overview of This Information
Collection
1. Type of Information Collection:
Revision of a currently approved
collection.
2. The Title of the Form/Collection:
Application for Registration and
Application for Registration Renewal.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
DEA Forms: 224, 224A. The applicable
component within the Department of
Justice is the Drug Enforcement
Administration, Diversion Control
Division.
4. Affected public who will be asked
or required to respond, as well as the
obligation to respond: Affected Public:
(Primary) Business or other for-profit.
Affected public (Other): Not-for-profit
institutions; Federal, State, local, and
tribal governments.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: The DEA estimates that
146,285 registrants participate in this
information collection for DEA Form
224, and 524,196 registrants for DEA
form 224A. The time per response is 20
minutes for DEA Form 224, and 10
minutes for DEA Form 224A.
6. An estimate of the total annual
burden (in hours) associated with the
collection: DEA estimates that this
collection takes 48,762 annual burden
hours for DEA Form 224 and 87,366
annual burden hours for DEA Form
224A.
7. An estimate of the total annual cost
burden associated with the collection, if
applicable: $0.
E:\FR\FM\07OCN1.SGM
07OCN1
81110
Federal Register / Vol. 89, No. 194 / Monday, October 7, 2024 / Notices
TOTAL BURDEN HOURS
Number of
respondents
Activity
Time per response
(hours)
Total annual
burden
(hours)
DEA—224 .......................................................
DEA—224A .....................................................
146,285
524,196
........................
........................
0.33 hours (20 minutes) .................................
0.17 hours (10 minutes) .................................
48,762
87,366
Unduplicated Totals .................................
670,481
........................
.........................................................................
136,366
If additional information is required
contact: Darwin Arceo, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, 4W–218,
Washington, DC 20530.
Dated: October 1, 2024.
Darwin Arceo,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2024–23027 Filed 10–4–24; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[OMB Number 1117–0060]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; New
Information Collection Request;
Emergency Medical Services
Recordkeeping and Notice
Requirements
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day notice.
AGENCY:
The Drug Enforcement
Administration (DEA), Department of
Justice (DOJ), will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
December 6, 2024.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Heather E. Achbach, Regulatory Drafting
and Policy Support Section, Drug
Enforcement Administration; Mailing
Address: 8701 Morrissette Drive,
Springfield, Virginia 22152; Telephone:
(571) 776–3882; Email: DEA.PRA@
dea.gov or Heather.E.Achbach@dea.gov.
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Total annual
responses
VerDate Sep<11>2014
17:11 Oct 04, 2024
Jkt 262001
Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Bureau of Justice
Statistics, including whether the
information will have practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Abstract: The Controlled Substances
Act (CSA) (21 U.S.C. 801–971) requires
all persons who handle controlled
substances to obtain a registration from
the Attorney General. 21 U.S.C. 822,
823, 831, 957, and 958. The ‘‘Protecting
Patient Access to Emergency
Medications Act of 2017,’’ (hereafter the
‘‘Act’’) which became law on November
17, 2017, amended the Controlled
Substances Act to allow for a new
registration category for emergency
medical services agencies that handle
controlled substances. It also
established standards for registering
emergency medical services agencies,
and set forth new requirements for
delivery, storage, and recordkeeping
related to their handling of controlled
substances.
With this proposed collection, DEA is
proposing recordkeeping regulations for
EMS agencies to incorporate the Act’s
CSA amendments regarding
recordkeeping, and to ensure an
accurate accounting of the controlled
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
substances outside the two-registrant
integrity system.
The Act require EMS agencies to
maintain records of the EMS personnel
whose State license or certification gives
them the ability to administer controlled
substances, in compliance with their
State laws. Under 21 U.S.C 827(b),
controlled substance records for all DEA
registrants are required to be maintained
for at least two years from the date of
such inventory or records. Following
the Act, 21 U.S.C. 823(k)(9)(B)(ii), DEA
would require that records be
maintained, whether electronically or
otherwise, at each registered and
designated location of the agency where
the controlled substances involved are
received, administered, or otherwise
disposed of.
Consistent with the Act’s
amendments to the CSA, 21 U.S.C.
823(k)(9), DEA would require an EMS
agency to maintain records for each
controlled substance administered or
disposed of in the course of providing
emergency medical services. In
addition, any EMS personnel who
disposes of or administers controlled
substances to a patient in the course of
providing emergency medical care
would have to record the name of the
controlled substance(s) and detailed
information about the circumstances
surrounding the administration of the
controlled substance(s) (e.g., name of
the substance, date dispensed,
identification of the patient).
Additionally, in accordance with 21
U.S.C 821(k)(9)(b), that an EMS agency
must maintain records of controlled
substances delivered between registered
and designated locations of the agency
(except agencies restocking at the
hospital under which the EMS agency is
operating, because the hospital is
required to keep records of such
restocking). These records, for example,
should include the name of the
controlled substance(s), finished form,
number of units in the commercial
container, date delivered, and the
address of the EMS agency location
where the controlled substances were
delivered.
E:\FR\FM\07OCN1.SGM
07OCN1
]]>Agencies
[Federal Register Volume 89, Number 194 (Monday, October 7, 2024)]
[Notices]
[Pages 81109-81110]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-23027]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1117-0014]
Agency Information Collection Activities; Proposed eCollection
eComments Requested; Revision of a Previously Approved Collection;
Application for Registration and Application for Registration Renewal;
DEA Forms 224, 224A
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 60-Day notice.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration (DEA), Department of
Justice (DOJ), will be submitting the following information collection
request to the Office of Management and Budget (OMB) for review and
approval in accordance with the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and will be accepted for 60 days until
December 6, 2024.
FOR FURTHER INFORMATION CONTACT: If you have additional comments
especially on the estimated public burden or associated response time,
suggestions, or need a copy of the proposed information collection
instrument with instructions or additional information, please contact
Heather E. Achbach, Regulatory Drafting and Policy Support Section,
Drug Enforcement Administration; Mailing Address: 8701 Morrissette
Drive, Springfield, Virginia 22152; Telephone: (571) 776-3882; Email:
[email protected] or [email protected].
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning the proposed collection of
information are encouraged. Your comments should address one or more of
the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the Bureau of Justice
Statistics, including whether the information will have practical
utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of
the information to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
Abstract: The Controlled Substances Act (CSA) (21 U.S.C. 801-971)
requires all persons that manufacture, distribute, dispense, conduct
research with, import, or export any controlled substance to obtain a
registration issued by the Attorney General. DEA would be revising the
proposed information collection instruments as statutorily mandated by
the Protecting Patient Access to Emergency Medications Act of 2017. DEA
would be creating a new business activity and adding it to forms DEA-
224 and DEA-224A to allow Emergency Medical Services agencies to
register as such, if authorized by state law. This new business
activity would allow EMS agencies to obtain a DEA registration that
will permit EMS agencies to deliver controlled substances to their
designated locations without obtaining a separate registration as a
Distributor. This registration would allow EMS personnel to administer
controlled substances outside the physical presence of a medical
director or authorizing medical professional in the course of providing
emergency medical services. Upon issuance of an EMS agency
registration, the EMS agency should use the online system to identify
all of the locations it intends to designate under the EMS agencies'
DEA registration. This proposed collection would also allow EMS
agencies to choose the option of a single registration in each state
where the EMS agency operates. If the agency operates EMS facilities in
multiple states, the agency must have a separate registration in each
state where the agency operates.
Overview of This Information Collection
1. Type of Information Collection: Revision of a currently approved
collection.
2. The Title of the Form/Collection: Application for Registration
and Application for Registration Renewal.
3. The agency form number, if any, and the applicable component of
the Department sponsoring the collection: DEA Forms: 224, 224A. The
applicable component within the Department of Justice is the Drug
Enforcement Administration, Diversion Control Division.
4. Affected public who will be asked or required to respond, as
well as the obligation to respond: Affected Public: (Primary) Business
or other for-profit.
Affected public (Other): Not-for-profit institutions; Federal,
State, local, and tribal governments.
5. An estimate of the total number of respondents and the amount of
time estimated for an average respondent to respond: The DEA estimates
that 146,285 registrants participate in this information collection for
DEA Form 224, and 524,196 registrants for DEA form 224A. The time per
response is 20 minutes for DEA Form 224, and 10 minutes for DEA Form
224A.
6. An estimate of the total annual burden (in hours) associated
with the collection: DEA estimates that this collection takes 48,762
annual burden hours for DEA Form 224 and 87,366 annual burden hours for
DEA Form 224A.
7. An estimate of the total annual cost burden associated with the
collection, if applicable: $0.
[[Page 81110]]
Total Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Total annual Time per response Total annual
Activity respondents responses (hours) burden (hours)
----------------------------------------------------------------------------------------------------------------
DEA--224.............................. 146,285 .............. 0.33 hours (20 minutes). 48,762
DEA--224A............................. 524,196 .............. 0.17 hours (10 minutes). 87,366
-------------------------------------------------------------------------
Unduplicated Totals............... 670,481 .............. ........................ 136,366
----------------------------------------------------------------------------------------------------------------
If additional information is required contact: Darwin Arceo,
Department Clearance Officer, United States Department of Justice,
Justice Management Division, Policy and Planning Staff, Two
Constitution Square, 145 N Street NE, 4W-218, Washington, DC 20530.
Dated: October 1, 2024.
Darwin Arceo,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2024-23027 Filed 10-4-24; 8:45 am]
BILLING CODE 4410-09-P
